Abstract
Whether high-dose clopidogrel may improve early clinical outcome has been debated. We compared the efficacy and safety of high-dose (600 mg) vs moderate-dose (300 mg) clopidogrel loading in patients with non-ST-elevation acute coronary syndrome (ACS) or stable angina who received drug-eluting stents and clarified treatment effects in several clinical and anatomic subgroups.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
